ATM/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer

ATM/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer

Background The efficacy of docetaxel-based chemotherapy is limited by the development of drug resistance. Recent studies demonstrated the efficacy of anti-programmed death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) immunotherapies in metastatic prostate cancer. The ataxia telangiectasia mutatio...

Full description

Bibliographic Details
Main Authors: Lan Shao, Bin Huang, Xinyao Zhang, Zongren Wang, Xueling Zhang, Wuguo Li, Qiao Su, Zhaoyang Huang, Haiqi Chen, Chengqiang Mo, Wei Ou, Junxing Chen, Guangyin Zhao, Lingwu Chen
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/7/e001758.full

Internet

https://jitc.bmj.com/content/9/7/e001758.full

Similar Items